Subtopic Deep Dive
Mangiferin in Diabetes
Research Guide
What is Mangiferin in Diabetes?
Mangiferin in Diabetes examines the antidiabetic effects of mangiferin, a xanthone C-glucoside from mango, on hyperglycemia, insulin sensitivity, and diabetic complications in preclinical models.
Studies demonstrate mangiferin's antihyperglycemic activity in streptozotocin-induced diabetic rats (Muruganandan et al., 2005, 424 citations). It protects against diabetic nephropathy via oxidative stress inhibition (Pal et al., 2014, 181 citations). Over 20 papers from the list address its mechanisms including AMPK activation and β-cell protection.
Why It Matters
Mangiferin reduces plasma glucose and free fatty acids in diabetic rats, offering a natural alternative for managing type 2 diabetes amid rising global prevalence (Muruganandan et al., 2005; Niu et al., 2012). It inhibits oxidative stress and TNFα pathways in nephropathy, potentially preventing kidney damage in diabetics (Pal et al., 2014). Imran et al. (2017) highlight its role in lifestyle disorders, supporting integration with synthetic antidiabetics (Alam et al., 2022).
Key Research Challenges
Low Oral Bioavailability
Mangiferin's poor absorption limits clinical translation despite strong preclinical antidiabetic effects. Du et al. (2018) note its rapid metabolism reduces systemic exposure. Strategies like nanoparticle formulations remain underexplored in diabetes models.
Human Clinical Data Gap
Most evidence derives from rodent STZ models, lacking human trials for diabetes endpoints. Sellamuthu et al. (2009) confirm efficacy in rats but highlight translation barriers. Alam et al. (2022) call for phase I safety studies in diabetic patients.
Mechanism Overlap Uncertainty
Mangiferin targets multiple pathways like AMPK and Nrf2, complicating dose-response modeling. Niu et al. (2012) show FFA catabolism via AMPK, but interactions with insulin signaling need clarification. Pal et al. (2014) identify oxidative stress inhibition without full pathway mapping.
Essential Papers
Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats
Shanmugam Muruganandan, K. K. Srinivasan, Shashi Gupta et al. · 2005 · Journal of Ethnopharmacology · 424 citations
Mangiferin: a natural miracle bioactive compound against lifestyle related disorders
Muhammad Imran, Muhammad Sajid Arshad, Masood Sadiq Butt et al. · 2017 · Lipids in Health and Disease · 330 citations
Antidiabetic Phytochemicals From Medicinal Plants: Prospective Candidates for New Drug Discovery and Development
Safaet Alam, Md. Moklesur Rahman Sarker, Taposhi Nahid Sultana et al. · 2022 · Frontiers in Endocrinology · 296 citations
Diabetes, a chronic physiological dysfunction affecting people of different age groups and severely impairs the harmony of peoples’ normal life worldwide. Despite the availability of insulin prepar...
Mangiferin Attenuates Diabetic Nephropathy by Inhibiting Oxidative Stress Mediated Signaling Cascade, TNFα Related and Mitochondrial Dependent Apoptotic Pathways in Streptozotocin-Induced Diabetic Rats
Pabitra Bikash Pal, Krishnendu Sinha, Parames C. Sil · 2014 · PLoS ONE · 181 citations
Oxidative stress plays a crucial role in the progression of diabetic nephropathy in hyperglycemic conditions. It has already been reported that mangiferin, a natural C-glucosyl xanthone and polyhyd...
Mangiferin: An effective therapeutic agent against several disorders (Review)
Suya Du, Huirong Liu, Tiantian Lei et al. · 2018 · Molecular Medicine Reports · 136 citations
Mangiferin (1,3,6,7‑tetrahydroxyxanthone‑C2‑β‑D‑glucoside) is a bioactive ingredient predominantly isolated from the mango tree, with potent antioxidant activity and multifactorial pharmacological ...
Quantification and Purification of Mangiferin from Chinese Mango (Mangifera indica L.) Cultivars and Its Protective Effect on Human Umbilical Vein Endothelial Cells under H2O2-induced Stress
Fenglei Luo, Qiang Lv, Yu‐Qin Zhao et al. · 2012 · International Journal of Molecular Sciences · 129 citations
Mangiferin is a natural xanthonoid with various biological activities. Quantification of mangiferin in fruit peel, pulp, and seed kernel was carried out in 11 Chinese mango (Mangifera indica L.) cu...
Antihyperglycemic Effect of Mangiferin in Streptozotocin Induced Diabetic Rats
Periyar Selvam Sellamuthu, Balu Periamallipatti Muniappan, Sathiya Moorthi Perumal et al. · 2009 · JOURNAL OF HEALTH SCIENCE · 121 citations
The study was undertaken to evaluate the antihyperglycemic potential of mangiferin purified from methanolic root extract of Salacia chinensis (S. chinensis) in control and streptozotocin (STZ)-indu...
Reading Guide
Foundational Papers
Start with Muruganandan et al. (2005, 424 citations) for core antihyperglycemic effects in STZ rats; follow with Pal et al. (2014, 181 citations) on nephropathy protection mechanisms; Sellamuthu et al. (2009, 121 citations) details dosing in diabetes models.
Recent Advances
Study Imran et al. (2017, 330 citations) for broad antidiabetic context; Alam et al. (2022, 296 citations) on drug discovery prospects; Du et al. (2018, 136 citations) reviews therapeutic applications.
Core Methods
Core techniques: STZ-induced diabetes in rats (Muruganandan 2005); AMPK activation assays (Niu 2012); oxidative stress markers like TNFα in nephropathy (Pal 2014); mangiferin quantification via HPLC (Luo 2012).
How PapersFlow Helps You Research Mangiferin in Diabetes
Discover & Search
Research Agent uses searchPapers and exaSearch to find 50+ papers on mangiferin-diabetes, revealing Muruganandan et al. (2005) as top-cited via citationGraph. findSimilarPapers expands from Pal et al. (2014) to nephropathy-focused studies.
Analyze & Verify
Analysis Agent applies readPaperContent to extract dose-response data from Sellamuthu et al. (2009), then runPythonAnalysis with pandas to meta-analyze glucose reductions across STZ rat studies. verifyResponse (CoVe) and GRADE grading confirm claims like AMPK activation in Niu et al. (2012) with statistical verification.
Synthesize & Write
Synthesis Agent detects gaps in clinical translation from Imran et al. (2017) papers, flagging human trial needs. Writing Agent uses latexEditText, latexSyncCitations for Muruganandan (2005), and latexCompile to generate review sections; exportMermaid visualizes mangiferin pathways from Pal et al. (2014).
Use Cases
"Meta-analyze glucose lowering effect sizes from mangiferin STZ rat studies."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis on extracted data from Muruganandan 2005, Sellamuthu 2009) → forest plot output with p-values.
"Draft LaTeX review on mangiferin nephropathy protection citing Pal 2014."
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Pal 2014, Niu 2012) + latexCompile → PDF with pathway diagram via exportMermaid.
"Find code for mangiferin pharmacokinetics simulation in diabetes models."
Research Agent → paperExtractUrls (Imran 2017) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for AMPK modeling output.
Automated Workflows
Deep Research workflow scans 50+ mangiferin papers, chains searchPapers → citationGraph → structured report on antidiabetic mechanisms from Muruganandan (2005). DeepScan applies 7-step verification to Pal et al. (2014) abstracts with CoVe checkpoints for oxidative stress claims. Theorizer generates hypotheses on mangiferin-metformin synergies from Alam et al. (2022).
Frequently Asked Questions
What is the definition of Mangiferin in Diabetes research?
Mangiferin in Diabetes research investigates the xanthone's effects on glucose metabolism, insulin sensitivity, and β-cell protection in diabetic models including pharmacokinetics.
What are key methods used in mangiferin diabetes studies?
Primary methods include streptozotocin (STZ)-induced diabetic rat models for hyperglycemia assessment (Muruganandan et al., 2005; Sellamuthu et al., 2009) and H2O2 stress assays on endothelial cells (Luo et al., 2012).
What are the most cited papers?
Top papers are Muruganandan et al. (2005, 424 citations) on hyperglycemia in STZ rats; Imran et al. (2017, 330 citations) on lifestyle disorders; Alam et al. (2022, 296 citations) on antidiabetic phytochemicals.
What open problems exist?
Challenges include poor bioavailability, lack of human trials, and unclear pathway interactions; Du et al. (2018) and Niu et al. (2012) emphasize need for clinical PK studies and combination therapy testing.
Research Mangiferin and Mango Extracts with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Mangiferin in Diabetes with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Mangiferin and Mango Extracts Research Guide